1. Home
  2. GERN vs PSIX Comparison

GERN vs PSIX Comparison

Compare GERN & PSIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Geron Corporation

GERN

Geron Corporation

HOLD

Current Price

$1.36

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Power Solutions International Inc.

PSIX

Power Solutions International Inc.

HOLD

Current Price

$41.86

Market Cap

935.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GERN
PSIX
Founded
1990
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
935.1M
IPO Year
1996
2011

Fundamental Metrics

Financial Performance
Metric
GERN
PSIX
Price
$1.36
$41.86
Analyst Decision
Hold
Strong Buy
Analyst Count
3
2
Target Price
$2.17
$99.95
AVG Volume (30 Days)
9.0M
311.5K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
51.85
64.12
EPS
N/A
1.05
Revenue
$1,065,000.00
$416,616,000.00
Revenue This Year
$26.91
$24.73
Revenue Next Year
$43.75
$16.20
P/E Ratio
N/A
$40.08
Revenue Growth
N/A
22.73
52 Week Low
$1.04
$25.28
52 Week High
$2.01
$119.16

Technical Indicators

Market Signals
Indicator
GERN
PSIX
Relative Strength Index (RSI) 40.83 56.80
Support Level $1.24 $35.47
Resistance Level $1.46 $43.89
Average True Range (ATR) 0.08 1.89
MACD -0.02 0.44
Stochastic Oscillator 3.85 59.41

Price Performance

Historical Comparison
GERN
PSIX

About GERN Geron Corporation

Geron Corp is a biopharmaceutical company focused on blood cancers. Its telomerase inhibitor, RYTELO (imetelstat), is approved in the United States and European Union for certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion-dependent anemia. RYTELO inhibits telomerase activity in malignant stem and progenitor cells, which may reduce abnormal cell proliferation while supporting the production of healthy cells. It is also conducting a Phase 3 trial of imetelstat in patients with JAK-inhibitor-refractory or relapsed myelofibrosis (R/R MF) and studies in other hematologic malignancies. The company operates as a single segment, being the development of therapeutic products for oncology.

About PSIX Power Solutions International Inc.

Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that run on nondiesel fuels, including natural gas, propane, and gasoline. The company's products are designed to meet emission standards imposed by environmental regulatory bodies like the Environmental Protection Agency. Its products are distributed to a wide range of industrial original equipment manufacturers that supply equipment to sectors including power generation, oil and gas, material handling, airport ground support, agricultural, turf, construction and irrigation. The company generates majority of its sales from United States, and also has its presence in North America (outside of United States), Pacific Rim, Europe and Others.

Share on Social Networks: